News and Press Releases
-
09/11/2012
Takeda California Battles Breast Cancer with 4th Annual Dog Walk in Partnership with Susan G. Komen for the Cure®, San Diego -
05/18/2012
Closure of Takeda California San Francisco Site and Relocation of Takeda Antibody and Biologics Research to San Diego
-
12/21/2011
Establishment of Takeda California, Inc. by Integration of Takeda San Diego, Inc. and Takeda San Francisco, Inc. -
12/20/2011
Takeda to Acquire Intellikine, Adding Two Novel Programs to its Oncology Pipeline -
11/21/2011
Takeda San Diego to Host Chili and Curry Cook-off to Raise Funds for the 9th Annual Holiday Party for San Diego Center for Children -
10/07/2011
Takeda San Diego and San Francisco led Four-Legged Friends in Annual Dog Walk to Raise Funds for Susan G. Komen for the Cure® -
09/23/2011
Takeda San Diego and San Francisco to Lead Four-Legged Friends in Annual Dog Walk to Raise Funds for Susan G. Komen for the Cure® -
05/23/2011
Takeda to Help Two Beloved San Diego Destinations on World Environment Day -
04/12/2011
Takeda San Diego Makes Enabling Donation to San Diego Center for Children -
02/23/2011
Approval of Additional Indications of “NESINA®”: Combination Therapy with Sulfonylurea and Combination Therapy with Biguanide for Type 2 Diabetes in Japan -
02/10/2011
Takeda San Diego Mobilizes to Support Three Local Non Profits -
01/10/2011
Takeda San Francisco and Pieris Sign Anticalin® Therapeutic Collaboration
-
12/17/2010
Takeda San Diego to Host 8th Annual Holiday Party for San Diego Center for Children -
10/06/2010
Takeda San Diego Leads Local Pharmaceutical Group Effort to Raise Funds for Susan G. Komen for the Cure® -
04/13/2010
Metabolex Initiates Research Collaboration with Takeda -
01/18/2010
One Hundred Takeda San Diego Employees Support the Martin Luther King Jr. Day of Service by Volunteering at St. Vincent de Paul Village and the San Diego River Garden
-
12/21/2009
Takeda San Diego Provides Holiday Season Festivities for Resident Adolescents at the San Diego Center for Children -
12/01/2009
Governor Schwarzenegger‘s Aide Attends Regional Business Mixer Hosted by Takeda San Diego -
10/30/2009
Takeda San Diego Employees Partner with Susan G. Komen for the Cure -
10/12/2009
Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences -
09/21/2009
Takeda San Francisco Enters Into A Sponsored Research Agreement With UCSF -
09/18/2009
Takeda San Diego Employees Team Up with the San Diego Food Bank to Fight Hunger -
08/28/2009
Cardiovascular Outcomes Trial for Alogliptin -
08/21/2009
Global Drug Maker Takeda Expands San Diego Operations -
06/26/2009
Complete Response Letter for Alogliptin -
05/28/2009
Takeda San Diego Employees to Observe World Environment Day by Helping to Restore Torrey Pines State Natural Reserve
-
12/24/2008
New Action Date for Alogliptin NDA -
10/10/2008
FDA Continues Review of Alogliptin NDA -
09/22/2008
President & CSO of Takeda San Francisco chairs the session about Expanding Research Capabilities through Global Partnerships: The New Symbiotic Relationship at 16th Annual BioPartnering Europe October 12-14, 2008 in London, UK -
09/08/2008
Takeda San Francisco, Inc. Appoints Gregory Landes, Ph.D. Vice President of Antibody Research -
05/22/2008
Takeda‘s Antibody Therapeutics Research Company, Takeda San Francisco, Inc. Appoints Mary Haak-Frendscho, Ph.D. as President and CSO -
02/03/2008
AMGEN and Takeda Announce Exclusive Collaboration in Japan on up to 13 AMGEN Clinical Candidates -
01/04/2008
Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.
-
11/19/2007
Takeda Established a New Company in the U.s. for Therapeutic Antibody Research -
09/05/2007
Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
-
11/02/2006
XOMA and Takeda Establish Collaboration for Therapeutic Antibody Discovery and Development -
07/02/2006
Takeda and Galaxy Biotech Sign License Agreement for Galaxy‘s Investigational Antibodies for the Treatment of Cancer -
04/02/2006
Takeda Enters into Joint Research Agreement with Arius on Functional Antibodies in Cancer Field